Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Keratins. Found 2 abstracts

Adams DL, Stefansson S, Haudenschild C, Martin SS, Charpentier M, Chumsri S, Cristofanilli M, Tang CM, Alpaugh RK. Cytometric characterization of circulating tumor cells captured by microfiltration and their correlation to the CellSearch((R)) CTC test. Cytometry A. 2015 Feb;87(2):137-44.
Tiezzi DG, Fernandez SV, Russo J. Epithelial mesenchymal transition during the neoplastic transformation of human breast epithelial cells by estrogen. International Journal of Oncology. 2007 Jan;31(4):823-7.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Keratins

Keratins Carcinoma (mammary ductal liquid biopsy CellSieve Male Monoclonal Antibodies Female Breast Neoplasms epithelial mesenchymal transition breast cancer Human Staining and Labeling pathology Neoplasm Antigens Cell Adhesion Molecules including toxicity) Transcription factors Role: ADV (Adverse effect-BSU (Biological study-unclassified)-BIOL (Biological study) (gene twist-TWIST1 including toxicity) Cadherins Role: ADV (Adverse effect-BSU (Biological study-unclassified)-BIOL (Biological study) (1 including toxicity) Transcription factor Smad Role: ADV (Adverse effect-BSU (Biological study-unclassified)-BIOL (Biological study) (Smad5 Transformation (epithelial mesenchymal transition during neoplastic transformation of human breast epithelial cells by estrogen) cancer phenotype characterization including toxicity) Vimentins Role: ADV (Adverse effect-BSU (Biological study-unclassified)-BIOL (Biological study) (epithelial mesenchymal transition during neoplastic transformation of human breast epithelial cells by estrogen) including toxicity) Transforming growth factor b Role: ADV (Adverse effect-BSU (Biological study-unclassified)-BIOL (Biological study) (TGFb2 immunology CD45 Antigens including toxicity) Glycoproteins Role: ADV (Adverse effect-BSU (Biological study-unclassified)-BIOL (Biological study) (BGP I (biliary glycoprotein I) including toxicity) Transforming growth factor b Role: ADV (Adverse effect-BSU (Biological study-unclassified)-BIOL (Biological study) (TGFb1 including toxicity) Ras proteins Role: ADV (Adverse effect-BSU (Biological study-unclassified)-BIOL (Biological study) (p21c-Ha-ras methods epithelial mesenchymal transition during neoplastic transformation of human breast epithelial cells by estrogen) Mammary gland (ductal carcinoma Circulating Neoplastic Cells including toxicity) Mucins Role: ADV (Adverse effect-BSU (Biological study-unclassified)-BIOL (Biological study) (MUC1 CellSearch including toxicity) Proteins Role: ADV (Adverse effect-BSU (Biological study-unclassified)-BIOL (Biological study) (Jagged 1 CTC cytometry including toxicity) Fibronectins Role: ADV (Adverse effect-BSU (Biological study-unclassified)-BIOL (Biological study) (I Tumor Biomarkers Flow Cytometry metabolism including toxicity) Transcription factors Role: ADV (Adverse effect-BSU (Biological study-unclassified)-BIOL (Biological study) (Snail-SNAIL2 Circulating Tumor Cells Prostatic Neoplasms blood Actins
Last updated on Tuesday, June 05, 2018